Metabolic issues in the antihypertensive and lipid-lowering heart attack trial study-Reference-Cited by-同舟云学术

Metabolic issues in the antihypertensive and lipid-lowering heart attack trial study

Published:2004-04 Issue:2 Volume:6 Page:106-110
ISSN:1522-6417
Container-title:Current Hypertension Reports
language:en
Short-container-title:Current Science Inc

Author:

Punzi Henry A.,Punzi Connie F.,

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11906-004-0084-7.pdf

Reference28 articles.

1. Chobanian AV, Bakris GL, Black HR, et al.: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560–2572. This important consensus statement reviews current blood pressure control rates, revised blood pressure classification with the addition of pre-hypertension, and the deletion of stage III hypertension. A multidrug, algorithm-driven approach to treatment and follow-up is proposed.

2. MacMahon S, Peto R, Cutler J, et al.: Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990, 35:765–774.

3. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin converting enzyme inhibitors or calcium channel blockers vs. diuretics. JAMA 2002, 288:2981–2997.

4. Davis BR, Cutler JA, Gordon DJ, et al.: Rationale and design for the antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT). JAMA 1996, 9:342–360.

5. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA 2000; 283:1967–1975. The ALLHAT trial is the largest randomized, double-blind trial ever done comparing chlorthalidone, amlodipine, lisinopril, and doxazosin in high-risk hypertensive patients.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypertension in Children with Type 2 Diabetes or the Metabolic Syndrome;Pediatric Hypertension;2023

2. Possible correction of thiazide-induced hypokalemia with co-administration of date palm fruits with hydrochlorothiazide in rats;Pharmacognosy Magazine;2022

3. Hypertension in Children with Type 2 Diabetes or the Metabolic Syndrome;Pediatric Hypertension;2022

4. The WNK signaling pathway and salt-sensitive hypertension;Hypertension Research;2020-04-14

5. Diabetic Neuropathy – Research;Microvascular Disease in Diabetes;2020-03-13